Skip to main content

GLYCOMIMETICS INC

For the period ended Jun 13, 2025. Filed Jun 18, 2025.

View on SEC.gov

About this filing

A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.

Jun 13, 2025 · Filed Jun 18, 2025

Use the contents to explore the available documents and sections.

CBIO$13.54+4.6%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

EX-99.2 · Convertible Notes Payable

Convertible Notes Payable

The Company accounts for the Convertible Note (as defined in Note 4) at amortized cost. The Company considered if optional conversion features are required to be bifurcated and separately accounted for as a derivative. Costs related to the issuance of the Convertible Note were recorded as a debt discount, amortized over the term of the Convertible Note (see Note 4) and were accounted for as interest expense in other income (expense), net within the condensed statement of operations and comprehensive loss using the effective interest method.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.